Exclusives
Research Review
02/13/2026
Jessica Garlewicz
Blood-based biomarkers may help identify fibrotic interstitial lung diseases, offering a less invasive adjunct to imaging and pulmonary function testing, according to a systematic review and meta-analysis.
Blood-based biomarkers may help identify fibrotic interstitial lung diseases, offering a less invasive adjunct to imaging and pulmonary function testing, according to a systematic review and meta-analysis.
Blood-based biomarkers may help...
02/13/2026
Rheumatology & Arthritis
Clinical Guidelines
02/13/2026
Jessica Garlewicz
The findings underscore the need for vigilance in monitoring patients with persistent respiratory symptoms after acute infection.
The findings underscore the need for vigilance in monitoring patients with persistent respiratory symptoms after acute infection.
The findings underscore the need...
02/13/2026
Rheumatology & Arthritis
Research Highlights
02/13/2026
Jessica Garlewicz
The authors highlight how new technologies may improve disease characterization, prognostication, and therapeutic decision-making.
The authors highlight how new technologies may improve disease characterization, prognostication, and therapeutic decision-making.
The authors highlight how new...
02/13/2026
Rheumatology & Arthritis
Research Highlights
02/10/2026
Rebecca Mashaw
The absence of a survival difference at 10 years highlights the progressive nature of ILD and underscores the need for ongoing disease-modifying therapies alongside supportive interventions like pulmonary rehabilitation.
The absence of a survival difference at 10 years highlights the progressive nature of ILD and underscores the need for ongoing disease-modifying therapies alongside supportive interventions like pulmonary rehabilitation.
The absence of a survival...
02/10/2026
Rheumatology & Arthritis
News
03/21/2023
While screening patients with systemic sclerosis (SSc) for interstitial lung disease (ILD) is important, the reverse – screening patients with ILD for SSc – is equally critical.
While screening patients with systemic sclerosis (SSc) for interstitial lung disease (ILD) is important, the reverse – screening patients with ILD for SSc – is equally critical.
While screening patients with...
03/21/2023
Rheumatology & Arthritis